These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33346446)

  • 1. [Morphological and immunohistochemical predictors of renal response to therapy patients with myeloma cast nephropathy and dialysis-dependent acute kidney injury].
    Rekhtina IG; Kazarina EV; Stolyarevich ES; Kovrigina AM; Dvirnyk VN; Kulikov SM; Mendeleeva LP
    Ter Arkh; 2020 Sep; 92(7):63-69. PubMed ID: 33346446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
    Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F
    Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful renal recovery from multiple myeloma-associated crystalline light chain cast nephropathy and accompanying acute kidney injury with early use of bortezomib-based therapy: a case report and literature review.
    Miki K; Shimamura Y; Maeda T; Moniwa N; Ogawa Y; Shimizu T; Hayashi T; Sakai H; Takizawa H
    CEN Case Rep; 2023 Feb; 12(1):56-62. PubMed ID: 35854043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.
    Yadav P; Hutchison CA; Basnayake K; Stringer S; Jesky M; Fifer L; Snell K; Pinney J; Drayson MT; Cook M; Cockwell P
    Eur J Haematol; 2016 Jun; 96(6):610-7. PubMed ID: 26248588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
    Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L
    Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dialysis-dependent renal failure in patients with multiple myeloma: Reversibility factors].
    Rekhtina IG; Mendeleeva LP; Biryukova LS
    Ter Arkh; 2015; 87(7):72-76. PubMed ID: 26390728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of acute kidney injury in symptomatic multiple myeloma.
    Bridoux F; Leung N; Belmouaz M; Royal V; Ronco P; Nasr SH; Fermand JP;
    Kidney Int; 2021 Mar; 99(3):570-580. PubMed ID: 33440212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of combined high cut-off haemodialysis and bortezomib for acute kidney injury associated with myeloma cast nephropathy.
    Ward F; Dunne O; Crotty TB; Fennelly D; Watson A; Holian J
    Ir Med J; 2012 May; 105(5):148-9. PubMed ID: 22803494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trial.
    Bridoux F; Fermand JP
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):333-41. PubMed ID: 22920644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion.
    Murgia S; Quattrocchio G; Forneris G; Pozzato M; Fenoglio R; Ferro M; De Simone E; Del Vecchio G; Di Benedetto C; Roccatello D
    J Nephrol; 2022 May; 35(4):1243-1249. PubMed ID: 34982413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney.
    Basnayake K; Cheung CK; Sheaff M; Fuggle W; Kamel D; Nakoinz S; Hutchison CA; Cook M; Stoves J; Bradwell AR; Cockwell P
    J Clin Pathol; 2010 Oct; 63(10):884-7. PubMed ID: 20876319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal outcome in multiple myeloma patients with cast nephropathy: a retrospective analysis of potential predictive values on clinical and renal outcome.
    Rüsing LZ; Kozakowski N; Jeryczynski G; Vospernik L; Riedl J; Reiter T; Gisslinger H; Agis H; Krauth MT
    Hematology; 2024 Dec; 29(1):2311600. PubMed ID: 38329272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
    Rosa J; Sydor A; Jurczyszyn A; Zabawa-Hołyś S; Nowak J; Czapkowicz-Gryszkiewicz L; Sułowicz W
    Przegl Lek; 2010; 67(7):547-50. PubMed ID: 21387773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney outcomes and prognostic factors of myeloma associated acute kidney injury in the contemporary era.
    Ratnayake C; Gibbs SDJ; Lee D
    Nephrology (Carlton); 2023 Oct; 28(10):561-566. PubMed ID: 37329237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
    Wu CK; Yang AH; Lai HC; Lin BS
    BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cut-off hemodialysis and bortezomib-based therapy to rescue kidneys in myeloma-dependent cast nephropathy.
    Sinisalo M; Silvennoinen R; Wirta O
    Am J Hematol; 2012 Jun; 87(6):640. PubMed ID: 22473521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report.
    Yong ZH; Yu XJ; Lin ZS; Zhou FD; Cen XN; Wang SX; Zhao MH
    BMC Nephrol; 2021 Jan; 22(1):6. PubMed ID: 33407225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.
    Fabbrini P; Finkel K; Gallieni M; Capasso G; Cavo M; Santoro A; Pasquali S
    J Nephrol; 2016 Dec; 29(6):735-746. PubMed ID: 27757797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report.
    Donati G; Zappulo F; Croci Chiocchini AL; Comai G; Zamagni E; La Manna G
    Hemodial Int; 2019 Jul; 23(3):E97-E99. PubMed ID: 30791209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two kinds of rare light chain cast nephropathy caused by multiple myeloma: case reports and literature review.
    Sun LJ; Dong HR; Xu XY; Wang GQ; Cheng H; Chen YP
    BMC Nephrol; 2021 Jan; 22(1):42. PubMed ID: 33509125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.